This site is intended for Healthcare Professionals only

Competition and Markets Authority


‘Material errors’: Drug firms overturn £35m collusion fines on appeal

Drug companies win appeal against the CMA's findings on prochlorperazine market entry.

28 May 2024 , 3 Min Article


Drug companies must ‘offer solutions’ to assuage HRT competition worries

Theramex's acquisition of Viatris HRT ranges could lead to price hikes, says CMA

04 Apr 2024 , 1 Min Article


Pharma companies fined £70m for ramping up phenytoin prices 2,500%

Pfizer and Flynn must face the consequences, says markets watchdog

21 Jul 2022 , 1 Min Article

medicine pill sumary.jpg

NPA wants competition watchdog to weigh in on hub & spoke

CMA should “look into” hub and spoke dispensing to ensure fairness, says NPA.

31 Aug 2021 , 1 Min Article

Money 700.jpg

Two of three accused companies admit price collusion

Two of three accused drug companies admit their part in an alleged anti-competitive agreement.

23 Jan 2020 , 1 Min Article